Growth Hormone Gene Family and Its Evolution

In this review, we will analyze the family of growth hormone (GH) genes, the territories where they are produced, the proteolytic generation of GH isoforms, both at the pituitary and tissue levels, the biological activity of these molecular forms, and we will describe the new variant GH-V2 and its effects biological. Finally, we will analyze the evolution of the hormone from its starting point with a common gene with PRL to its actions in the most evolved organisms as a true prohormone

Pituitary Growth Hormone Secretion and Cell Growth Hormone Production: Regulation of Their Secretion and Their Signaling Pathways

Growth hormone (GH) performs very diverse functions in the organism, and this is the reason by which the regulation of the secretion of this hormone is very complex; although the primary regulators are growth hormone-releasing hormone (GHRH) and somatostatin, it is in turn regulated mainly by adrenergic and cholinergic pathways, and other factors can act directly on its secretion, particularly on the somatostatin, thus affecting the pituitary secretion of GH. In this chapter, we will analyze the transcription of GH gene and how GH release is affected by different neurotransmitters, metabolic substrates, feeding and fasting, and other hormones, placing special emphasis on why pituitary secretion of GH is sexually dimorphic

Growth Hormone (GH) and Cardiovascular System

This review describes the positive effects of growth hormone (GH) on the cardiovascular system. We analyze why the vascular endothelium is a real internal secretion gland, whose inflammation is the first step for developing atherosclerosis, as well as the mechanisms by which GH acts on vessels improving oxidative stress imbalance and endothelial dysfunction. We also report how GH acts on coronary arterial disease and heart failure, and on peripheral arterial disease, inducing a neovascularization process that finally increases flow in ischemic tissues. We include some preliminary data from a trial in which GH or placebo is given to elderly people suffering from critical limb ischemia, showing some of the benefits of the hormone on plasma markers of inflammation, and the safety of GH administration during short periods of time, even in diabetic patients. We also analyze how Klotho is strongly related to GH, inducing, after being released from the damaged vascular endothelium, the pituitary secretion of GH, most likely to repair the injury in the ischemic tissues. We also show how GH can help during wound healing by increasing the blood flow and some neurotrophic and growth factors. In summary, we postulate that short-term GH administration could be useful to treat cardiovascular diseases

Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy

Cerebral palsy is an important health issue that has a strong socioeconomic impact. There is no cure for cerebral palsy, and therapeutic approaches only report small benefits for affected people. In this study we assessed the effects of growth hormone treatment (0.3 μg/kg/day) combined with physical rehabilitation in the recovery of gross motor function in children with growth hormone deficiency and cerebral palsy (four males and six females, mean age 5.63 ± 2.32 years) as compared with that observed in a similar population of cerebral palsy children (five males, five females, mean age 5.9 ± 2.18 years) without growth hormone deficiency treated only with physical rehabilitation for two months. The Gross Motor Function Measure (GMFM-88) and Modified Ashworth Scale were performed before commencing the treatment and after completion thereof. In children with cerebral palsy and growth hormone deficiency, Dimension A (P < 0.02), dimension B (P < 0.02), and dimension C (P < 0.02) of the GMFM-88, and the total score of the test (P < 0.01) significantly improved after the treatment; dimension D and dimension E did not increase, and four of five spastic patients showed a reduction in spasticity. However, in children with cerebral palsy and without growth hormone deficiency, only the total score of the test improved significantly after the treatment period. This indicates that growth hormone replacement therapy was responsible for the large differences observed between both groups in response to physical rehabilitation. We propose that the combined therapy involving growth hormone administration and physical rehabilitation may be a useful therapeutic approach in the recovery of gross motor function in children with growth hormone deficiency and cerebral palsy

Recovery from neurological sequelae secondary to oncological brain surgery in an adult growth hormone-deficient patient after growth hormone treatment

[Abstract] Objective: To report an unusual case of significant neurological recovery in a 26-year-old growth hormone-deficient female patient with significant neurological sequelae resulting from brain surgery at 11 years of age. Design: Case report. Results: Most of the neurological sequelae present at admission recovered after 8 months of combined growth hormone administration and kinesitherapy/speech therapy. These include an increase in tongue size and mobility and in the amount and quality of saliva, improvement in vocal cords function, recovery of oesophageal peristalsis and disappearance of sleep apnoea. Conclusion: Since the patient had undergone intensive physical rehabilitation for a 15-year period with no significant improvement, it is tempting to speculate that the correction of growth hormone deficiency improved her rehabilitation. Therefore, we propose that growth hormone treatment, combined with the adequate kinesitherapy, may be a useful therapy for effective recovery from some neurological deficits in patients with growth hormone deficiency

Tracking volcanic explosions using Shannon entropy at Volcán de Colima

The main objective of this work is to show that Shannon Entropy (SE) calculated on continuous seismic signals can be used in a volcanic eruption monitoring system. We analysed three years of volcanic activity of Volcán de Colima, México, recorded between January 2015 and May 2017. This period includes two large explosions, with pyroclastic and lava flows, and intense activity of less energetic explosion, culminating with a period of quiescence. In order to confirm the success of our results, we used images of the Visual Monitoring system of Colima Volcano Observatory. Another of the objectives of this work is to show how the decrease in SE values can be used to track minor explosive activity, helping Machine Learning algorithms to work more efficiently in the complex problem of distinguishing the explosion signals in the seismograms. We show that the two big eruptions selected were forecasted successfully (6 and 2 days respectively) using the decay of SE. We conclude that SE could be used as a complementary tool in seismic volcano monitoring, showing its successful behaviour prior to energetic eruptions, giving time enough to alert the population and prepare for the consequences of an imminent and well predicted moment of the eruption.FEMALE (PID2019-106260GB-I00)PROOF-FOREVER (EUR2022.134044) projectsMinisterio de Ciencia e Innovación del Gobierno de España (MCIN)Agencia Estatal de Investigación (AEI)Fondo Social Europeo (FSE)Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+I Ayudas para contratos predoctorales para la formación de doctores 2020 (PRE2020-092719

Brain Recovery after a Plane Crash: Treatment with Growth Hormone (GH) and Neurorehabilitation: A Case Report

This study was supported by Foundation FoltraThe aim of this study is to describe the results obtained after growth hormone (GH) treatment and neurorehabilitation in a young man that suffered a very grave traumatic brain injury (TBI) after a plane crash. Methods: Fifteen months after the accident, the patient was treated with GH, 1 mg/day, at three-month intervals, followed by one-month resting, together with daily neurorehabilitation. Blood analysis at admission showed that no pituitary deficits existed. At admission, the patient presented: spastic tetraplegia, dysarthria, dysphagia, very severe cognitive deficits and joint deformities. Computerized tomography scanners (CT-Scans) revealed the practical loss of the right brain hemisphere and important injuries in the left one. Clinical and blood analysis assessments were performed every three months for three years. Feet surgery was needed because of irreducible equinovarus. Results: Clinical and kinesitherapy assessments revealed a prompt improvement in cognitive functions, dysarthria and dysphagia disappeared and three years later the patient was able to live a practically normal life, walking alone and coming back to his studies. No adverse effects were observed during and after GH administration. Conclusions: These results, together with previous results from our group, indicate that GH treatment is safe and effective for helping neurorehabilitation in TBI patients, once the acute phase is resolved, regardless of whether or not they have GH-deficiency (GHD)S

Factors Involved in the Functional Motor Recovery of Rats with Cortical Ablation after GH and Rehabilitation Treatment: Cortical Cell Proliferation and Nestin and Actin Expression in the Striatum and Thalamus

Previously we demonstrated, in rats, that treatment with growth hormone (GH) and rehabilitation, carried out immediately after a motor cortical ablation, significantly improved the motor affectation produced by the lesion and induced the re-expression of nestin in the contralateral motor cortex. Here we analyze cortical proliferation after ablation of the frontal motor cortex and investigate the re-expression of nestin in the contralateral motor cortex and the role of the striatum and thalamus in motor recovery. The rats were subjected to ablation of the frontal motor cortex in the dominant hemisphere or sham-operated and immediately treated with GH or the vehicle (V), for five days. At 1 dpi (days post-injury), all rats received daily injections (for four days) of bromodeoxyuridine and five rats were sacrificed at 5 dpi. The other 15 rats (n = 5/group) underwent rehabilitation and were sacrificed at 25 dpi. GH induced the greatest number of proliferating cells in the perilesional cortex. GH and rehabilitation produced the functional recovery of the motor lesion and increased the expression of nestin in the striatum. In the thalamic ventral nucleus ipsilateral to the lesion, cells positive for nestin and actin were detected, but this was independent on GH. Our data suggest that GH-induced striatal nestin is involved in motor recoveryThis research was funded by Foundation Foltra (Teo, Spain), grant number 2018-8S